UBS AG is offering $1,570,000 ($1.57 million) of trigger autocallable notes linked to the least performing of three indexes, with Maturity on September 25, 2031. Investors face unsecured UBS Credit exposure, no deposit insurance, index-linked automatic calls and the possibility of limited secondary-market liquidity.
Key Highlights
- The final valuation date is included among the observation dates used to test for an automatic call.
- The public issue price is $1,000 per note.
- Notes mature on September 25, 2031.
- Public issue price is $1,000 per note, with total proceeds to UBS AG of $1,513,087.50.
The unsubordinated, unsecured notes mature on September 25, 2031, and may be called automatically when each underlying index meets its call threshold on an observation date.
$1,000 Note Pricing And Offering Economics
The public issue price is $1,000 per note, with total proceeds to UBS AG of $1,513,087.50. The aggregate public offering amount is $1,570,000, while Underwriting compensation totals $56,912.50. UBS will also periodically pay unaffiliated dealers a $5.00 structuring fee per note.
Unsecured Exposure And Secondary-Market Conditions
The initial public price may temporarily exceed UBS’s internal model valuation because it includes underwriting, hedging and issuance costs, along with theoretical projected trading profit.
FAQs
Q: How much do UBS AG trigger autocallable notes cost per note?
A: The public issue price for each UBS AG trigger autocallable note is $1,000. The offering’s total public amount is $1,570,000.
Q: What credit protection do UBS AG note investors receive?
A: Investors receive no secured protection; the notes are unsubordinated and unsecured obligations of UBS AG.
Q: When can UBS AG notes be automatically called?
A: UBS AG notes may be automatically called on an observation date when each underlying index meets its call threshold.
Download Free Report – Explore 3 Stock Ideas & Industry Insights
Unlock 3 stock ideas and key industry insights in our free report. This information is general in nature and does not consider your personal objectives, financial situation, or needs. It is not financial advice.
All investments involve risk—consider independent advice before making any investment decisions.
View 3 Research Reports
Disclaimer:
Kalkine Equities LLC, with Delaware File Number 4697384, Foreign Qualification Registration in California File Number 202109211078, and Texas File Number 805521396, is authorized to provide general advice only. The information on https://kalkine.com/ does not take into account any of your investment objectives, financial situation or needs. You should consider the appropriateness of advice taking into account your own objectives, financial situation and needs and seek independent financial advice before making any financial decisions. The link to our Terms and Conditions and Privacy Policy has been provided for your reference. On the date of publishing the reports (mentioned on the website), employees and/or associates of Kalkine do not hold positions in any of the stocks covered on the website. These stocks can change any time and readers of the reports should not consider these stocks as advice or recommendations later.